Designing and planning of R&D studies

During project assessment we always think about commercialization of the results to be generated. In the case of medicinal products, product launch is preceded by the registration process when dossier containing physicochemical, non-clinical and clinical study results is evaluated. Registration agency experts have to assess the risk/benefit ratio for drug product which in turn determines whether the product can or cannot be placed on the market.

In SciencePharma we always designing of R&D studies to comply with the registration requirements finding such an approach as optimal because reduces the risk of methodological errors and is timely and costly effective.